We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App




XT MicroSlide Assays Evaluated for Performance

By LabMedica International staff writers
Posted on 22 Jun 2022

One of the challenges clinical laboratories face when servicing pediatric centers is adequate specimen collection from infants and children in addition to performing multiple tests on the limited sample volume. More...

This challenge is significantly heightened in critically ill patients and in patients for whom phlebotomy is challenging. Diagnostic phlebotomy is a known cause of iatrogenic blood loss which can result in the aggravation of hospital-acquired anemia.

Clinical Biochemists at the Baylor College of Medicine (Houston, TX, USA) and their colleagues evaluated the analytical performance of the Vitros XT MicroSlide assay pairs on the Vitros XT 7600 (Ortho Clinical Diagnostics, Raritan NJ, USA) compared to single MicroSlides. Performance characteristics included within-run precision, analytical measurable range, method comparison, and interference verification.

The investigators compared six XT MicroSlide pairs on the Vitros XT 7600 with twelve corresponding single slide assays on the Vitros 5600 system. Currently available Vitros XT MicroSlide pairs include Alanine Aminotransferase/Aspartate Aminotransferase [ALTV-AST], Triglyceride/Cholesterol [TRIG-CHOL], Albumin/Total Protein [ALB-TP], Urea/Creatinine [UREA-CREA], Glucose/Calcium [GLU-CA], Total Bilirubin/Alkaline Phosphatase [TBIL-ALKP].

The scientists reported that the XT MicroSlides on Vitros XT 7600 demonstrated excellent precision, equivalent analytical measurable range, and strong method correlation with single slide assays on Vitros 5600 for most of the assays tested. Within-run CVs of the analytes ranged between 0.32% and 2.93% with between-run CV of less than 8.8% and linearity for all analytes was within the manufacturer's specified range. Interference studies showed comparable effects of hemolysis, lipemia, and bilirubin on both instruments. The total turnaround time (TAT), the XT7600 had a TAT of 31 minutes and 2 seconds compared to 69 minutes 2 seconds on the 5600. Similarly, the volume of samples utilized by the XT7600 was 53% less than the volume required by the 5600.

The authors concluded that the XT MicroSlide assays on the XT 7600 demonstrated comparable analytical measurement ranges, precision, and strong method correlation with the Single MicroSlides for all the assays. It is suitable for use in the pediatric setting as it accommodates lower sample volumes and improved turnaround times without any effect on performance. The study was published in the August 1, 2022 issue of the journal Practical Laboratory Medicine.

Related Links:
Baylor College of Medicine 
Ortho Clinical Diagnostics 


New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The circulating tumor DNA blood test could provide earlier warning of post-transplant recurrence (Photo courtesy of Shutterstock)

Blood Test Could Enable Earlier Detection of Liver Cancer Recurrence After Transplant

Liver cancer is a leading cause of cancer deaths worldwide, with more than 800,000 diagnoses and over 700,000 deaths each year. Disease recurrence after liver transplantation is common and is associated... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.